期刊文献+

北京天坛地区恶性肿瘤死亡原因分析 被引量:2

Analysis of the Death Cause for Malignant Tumors at Beijing Tiantan Region
下载PDF
导出
摘要 通过总结分析北京天坛社区恶性肿瘤死亡率的变化趋势 ,为恶性肿瘤的社区防治工作提供指导依据。结果显示 :在被调查人口前 5位死因中恶性肿瘤死亡人数占全死因的 2 1 .0 5 % ,居第 2位 ;其中消化系统恶性肿瘤占全部恶性肿瘤总构成比的 5 1 % ,消化系统恶性肿瘤中胃癌居首位 ,肝癌次之。提示 :应重视消化系统恶性肿瘤的防治 。 By summarize and analyze the changes and trends in malignant tumor death rates so as to lay foundations for malignant tumor protection in the community. The results indicated that the ratio of people died of malignant tumor was 21.05% of the total deaths and ranked the second in the first five causes of death for the people. The constituent ratio of malignant tumor in the digestive system was 51%, among which stomach cancer ranked the first, followed by live cancer. So the prevention of malignant tumors in the digestive system should be emphasized, and the first-grade prevention and second-grade prevention should be the focuses of the work.
出处 《首都医科大学学报》 CAS 2003年第3期272-274,共3页 Journal of Capital Medical University
关键词 北京 天坛地区 恶性肿瘤 死亡原因 人口资料 malignant tumor death cause prevention
  • 相关文献

参考文献4

二级参考文献17

共引文献280

同被引文献16

  • 1陈竺.全国第三次死因回顾抽样调查报告[M].北京:中国协和医科大学出版社,2008:11-12.
  • 2Ajani JA,Fodor MB,Tjulandin SA,et al. Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluo- rouracil in patients with untreated,advanced gastric,or gastroe- sophageal adenocarcinoma [ J ]. J Clin Oncol, 2005,23 (24) : 5660 - 5667.
  • 3Shah MA,Schwartz GK. Treatment of metastatic esophagus and gastric cancer [ J ]. Semin Oncol, 2004,31 (4) : 574-587.
  • 4Qiu MZ, Xu RH, Ruan DY, et al. Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China [J]. Tu- mour Biol,2010,31(6) :633-641.
  • 5Chau I,Norman AR,Cunningham D,et al. Multivariate prognostic factor analysis in locally advanced and metastatic esophagogastric cancer-pooled analysis from three muhicenter,randomized,con- trolled trims using individual patient data[ J ]. J Clin Oncol, 2004,22 (12) :2395-2403.
  • 6Lee J,Li T,Uhm JE,et al. Prognostic model to predict survival fol- lowing first-line chemotherapy in patients with metastatic gastric ade- nocarcinoma[ J ]. Ann Oncol, 2007,18 (5) : 886-891.
  • 7Hwang SG, Kim KM, Cheong JH, et al. Impact of pretreatment throm- bocytosis on blood-borne metastasis and prognosis of gastric cancer [ J ]. Eur J Surg Oncol, 2012,38 (7) : 562-567.
  • 8Mohri Y, Tanaka K, Ohi M, et al. Prognostic significance of host- and tumor-related factors in patients with gastric cancer [J]. World J Surg,2010,34(2) : 285-290.
  • 9Yoshida M, Ohtsu A, Boku N, et al. Long-term survival and prognos- tic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Ontology Group (JCOG) study [ J ]. Jpn J Clin Oncol, 2004,34( 11 ) : 654-659.
  • 10Kanagavel D, Pokataev IA, Fedyanin MY. A prognostic model in pa- tients treated for metastatic gastric cancer with second-line chemotherapy [ J ]. Ann Oncol, 2010,21 (9) : 1779-1785.

引证文献2

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部